PT - JOURNAL ARTICLE AU - Torsten Seemann AU - Courtney R Lane AU - Norelle L Sherry AU - Sebastian Duchene AU - Anders Gonçalves da Silva AU - Leon Caly AU - Michelle Sait AU - Susan A Ballard AU - Kristy Horan AU - Mark B Schultz AU - Tuyet Hoang AU - Marion Easton AU - Sally Dougall AU - Timothy P Stinear AU - Julian Druce AU - Mike Catton AU - Brett Sutton AU - Annaliese van Diemen AU - Charles Alpren AU - Deborah A Williamson AU - Benjamin P Howden TI - Tracking the COVID-19 pandemic in Australia using genomics AID - 10.1101/2020.05.12.20099929 DP - 2020 Jan 01 TA - medRxiv PG - 2020.05.12.20099929 4099 - http://medrxiv.org/content/early/2020/05/16/2020.05.12.20099929.short 4100 - http://medrxiv.org/content/early/2020/05/16/2020.05.12.20099929.full AB - BACKGROUND Whole-genome sequencing of pathogens can improve resolution of outbreak clusters and define possible transmission networks. We applied high-throughput genome sequencing of SARS-CoV-2 to 75% of cases in the State of Victoria (population 6.24 million) in Australia.METHODS Cases of SARS-CoV-2 infection were detected through active case finding and contact tracing. A dedicated SARS-CoV-2 multidisciplinary genomic response team was formed to enable rapid integration of epidemiological and genomic data. Phylodynamic analysis was performed to assess the putative impact of social restrictions.RESULTS Between 25 January and 14 April 2020, 1,333 COVID-19 cases were reported in Victoria, with a peak in late March. After applying internal quality control parameters, 903 samples were included in genomic analyses. Sequenced samples from Australia were representative of the global diversity of SARS-CoV-2, consistent with epidemiological findings of multiple importations and limited onward transmission. In total, 76 distinct genomic clusters were identified; these included large clusters associated with social venues, healthcare facilities and cruise ships. Sequencing of sequential samples from 98 patients revealed minimal intra-patient SARS-CoV-2 genomic diversity. Phylodynamic modelling indicated a significant reduction in the effective viral reproductive number (Re) from 1.63 to 0.48 after the implementation of travel restrictions and population-level physical distancing.CONCLUSIONS Our data provide a comprehensive framework for the use of SARS-CoV-2 genomics in public health responses. The application of genomics to rapidly identify SARS-CoV-2 transmission chains will become critically important as social restrictions ease globally. Public health responses to emergent cases must be swift, highly focused and effective.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThe Victorian Infectious Diseases Reference Laboratory (VIDRL) and the Microbiological Diagnostic Unit Public Health Laboratory (MDU PHL) at The Doherty Institute are funded by the Victorian Government. This work was supported by the National Health and Medical Research Council, Australia (NHMRC); Partnership Grant (APP1149991), Practitioner Fellowship to BPH (APP1105905), Investigator Grant to DAW (APP1174555), Research Fellowship to TPS (APP1105525).Author DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesConsensus sequences and Illumina sequencing reads were deposited into GenBank under BioProject PRJNA613958 (Supplementary Data). Consensus genome sequences are also available from https://github.com/MDU-PHL/COVID19-paper.